Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Abstract LB081: Novel targeted oligonucleotide-based telomere disruptor for immunotherapy of diffuse large B-cell lymphoma

Chunsong Yu, Yong Liang, Piotr Swiderski, Larry Kwak, Marcin Kortylewski

Cancer Res (2024) 84 (7_Supplement): LB081.

https://doi.org/10.1158/1538-7445.AM2024-LB081

Published: 05 April 2024

View article titled, Abstract LB081: Novel targeted oligonucleotide-based telomere disruptor for immunotherapy of diffuse large B-cell lymphoma

Journal Articles

Abstract 2364: ABI1 regulates transcriptional activity of STAT3

Xiang Li, Baylee Porter, Allysa Kemraj, Alaji Bah, Marcin Kortylewski, Leszek Kotula

Cancer Res (2022) 82 (12_Supplement): 2364.

https://doi.org/10.1158/1538-7445.AM2022-2364

Published: 15 June 2022

View article titled, Abstract 2364: ABI1 regulates transcriptional activity of STAT3

Journal Articles

Abstract 2097: Characterization of mouse and cellular phenotype of ABI1 KO T-cells

Maria Altagracia Ortiz, Andras Perl, Marcin Kortylewski, Leszek Kotula

Cancer Res (2022) 82 (12_Supplement): 2097.

https://doi.org/10.1158/1538-7445.AM2022-2097

Published: 15 June 2022

View article titled, Abstract 2097: Characterization of mouse and cellular phenotype of ABI1 KO T-cells

Journal Articles

Abstract 1570: STAT3 inhibition allows for TLR9-induced reprogramming of acute myeloid leukemia into antigen-presenting cells to generate T-cell mediated immune responses

Yu-Lin Su, Dongfang Wang, Priyanka Duttagupta, Hiqing Li, Ya-Huei Kuo, Guido Marcucci, Marcin Kortylewski

Cancer Res (2021) 81 (13_Supplement): 1570.

https://doi.org/10.1158/1538-7445.AM2021-1570

Published: 01 July 2021

View article titled, Abstract 1570: STAT3 inhibition allows for TLR9-induced reprogramming of acute myeloid leukemia into antigen-presenting cells to generate T-cell mediated immune responses

Journal Articles

Abstract 677: Immune biomarkers of response to Ra223 dichloride and stereotactic body radiation therapy in patients with oligometastatic prostate cancers

Marice Alcantara, Tanya Dorff, Jessica Liu, Paul Frankel, Przemyslaw Twardowski, Savita Dandapani, Marcin Kortylewski

Cancer Res (2021) 81 (13_Supplement): 677.

https://doi.org/10.1158/1538-7445.AM2021-677

Published: 01 July 2021

View article titled, Abstract 677: Immune biomarkers of response to Ra223 dichloride and stereotactic body radiation therapy in patients with oligometastatic prostate cancers

Journal Articles

Abstract 1761: Defining ABI1 role in T-Cell signaling

Maria Altagracia Ortiz, Marcin Kortylewski, Andras Perl, Leszek Kotula

Cancer Res (2021) 81 (13_Supplement): 1761.

https://doi.org/10.1158/1538-7445.AM2021-1761

Published: 01 July 2021

View article titled, Abstract 1761: Defining ABI1 role in T-Cell signaling

Journal Articles

Abstract 5356: Targeted in vivo delivery of NF-κB decoy oligodeoxynucleotide augments efficacy of radiation therapy against B-cell lymphomas

Zhuoran zhang, Xingli Zhao, Dayson Moreira, Yu-Lin Su, Piotr Swiderski, Stephen Forman, Larry Kwak, Marcin Kortylewski

Cancer Res (2020) 80 (16_Supplement): 5356.

https://doi.org/10.1158/1538-7445.AM2020-5356

Published: 15 August 2020

View article titled, Abstract 5356: Targeted in vivo delivery of NF-κB decoy oligodeoxynucleotide augments efficacy of radiation therapy against B-cell lymphomas

Journal Articles

Abstract LB-058: ABIraterone (ABI) and ENZalutamide (ENZ) induce changes in immunologic profile of patients with metastatic castration-resistant prostate cancer (mCRPC)

Meghan Salgia, Marc L. Perez, Jeremy Jones, Hae Jung Won, Valeriy Poroyko, Przemyslaw Twardowski, Marcin Kortylewski, Sumanta K. Pal

Cancer Res (2017) 77 (13_Supplement): LB-058.

https://doi.org/10.1158/1538-7445.AM2017-LB-058

Published: 01 July 2017

View article titled, Abstract LB-058: ABIraterone (ABI) and ENZalutamide (ENZ) induce changes in immunologic profile of patients with metastatic castration-resistant prostate cancer (mCRPC)

Journal Articles

Abstract 375: Phenotypic and molecular characterization of circulating tumor cells (CTCs) in patients with castration resistant prostate cancer (CRPC) undergoing treatment with abiraterone acetate or enzalutamide

Jaymala Patel, Vipul Bhargava, Miaoling He, Brad Foulk, Denis A. Smirnov, Przemyslaw Twardowski, Marcin Kortylewski, Sumanta Kumar Pal, Jeremy O. Jones

Cancer Res (2015) 75 (15_Supplement): 375.

https://doi.org/10.1158/1538-7445.AM2015-375

Published: 01 August 2015

View article titled, Abstract 375: Phenotypic and molecular characterization of circulating tumor cells (CTCs) in patients with castration resistant prostate cancer (CRPC) undergoing treatment with abiraterone acetate or enzalutamide

Journal Articles

Abstract CT334: Pazopanib as third-line therapy for metastatic renal cell carcinoma: Clinical efficacy and temporal analysis of cytokine profile

Sumanta K. Pal, Dewan Md Sakib Hossain, Qifang Zhang, Chan Gao, Jeremy O. Jones, Paul H. Frankel, Robert A. Figlin, Marcin Kortylewski

Cancer Res (2014) 74 (19_Supplement): CT334.

https://doi.org/10.1158/1538-7445.AM2014-CT334

Published: 01 October 2014

View article titled, Abstract CT334: Pazopanib as third-line therapy for metastatic renal cell carcinoma: Clinical efficacy and temporal analysis of cytokine profile

Journal Articles

Abstract 2569: Systemic delivery of STAT3 blocking/TLR9 activating oligodeoxynucleotides induces regression of mouse and human acute myeloid leukemia

Qifang Zhang, Ralf Buettner, Sergey Nechaev, Dayson Moreira, Agnieszka Jozwiak, Piotr Swiderski, Marcin Kortylewski

Cancer Res (2014) 74 (19_Supplement): 2569.

https://doi.org/10.1158/1538-7445.AM2014-2569

Published: 01 October 2014

View article titled, Abstract 2569: Systemic delivery of STAT3 blocking/TLR9 activating oligodeoxynucleotides induces regression of mouse and human acute myeloid leukemia

Journal Articles

TLR9 Is Critical for Glioma Stem Cell Maintenance and Targeting

Cancer Res (2014) 74 (18): 5218–5228.

https://doi.org/10.1158/0008-5472.CAN-14-1151

Published: 14 September 2014

View article titled, TLR9 Is Critical for Glioma Stem Cell Maintenance and Targeting

Includes: Supplementary data

Journal Articles

TLR9 Signaling in the Tumor Microenvironment Initiates Cancer Recurrence after Radiotherapy

Chan Gao, Anna Kozlowska, Sergey Nechaev, Haiqing Li, Qifang Zhang, Dewan M.S. Hossain, Claudia M. Kowolik, Peiguo Chu, Piotr Swiderski, Don J. Diamond, Sumanta K. Pal, Andrew Raubitschek, Marcin Kortylewski

Cancer Res (2013) 73 (24): 7211–7221.

https://doi.org/10.1158/0008-5472.CAN-13-1314

Published: 16 December 2013

View article titled, TLR9 Signaling in the Tumor Microenvironment Initiates Cancer Recurrence after Radiotherapy

Journal Articles

Abstract LB-334: CpG-STAT3 siRNA for two-pronged immunotherapy of acute myeloid leukemia .

Sakib D M Hossain, Cedric Dos Santos, Qifang Zhang, Hongjun Liu, Piotr Swiderski, Claudia Kowolik, Stephen Forman, Ravi Bhatia, Ya-Huei Kuo, Marcin Kortylewski

Cancer Res (2013) 73 (8_Supplement): LB-334.

https://doi.org/10.1158/1538-7445.AM2013-LB-334

Published: 15 April 2013

View article titled, Abstract LB-334: CpG-<em>STAT3</em> siRNA for two-pronged immunotherapy of acute myeloid leukemia .

Journal Articles

Targeting Stat3 in the Myeloid Compartment Drastically Improves the In vivo Antitumor Functions of Adoptively Transferred T Cells

Andreas Herrmann, Marcin Kortylewski, Maciej Kujawski, Chunyan Zhang, Karen Reckamp, Brian Armstrong, Lin Wang, Claudia Kowolik, Jiehui Deng, Robert Figlin, Hua Yu

Cancer Res (2010) 70 (19): 7455–7464.

https://doi.org/10.1158/0008-5472.CAN-10-0736

Published: 29 September 2010

View article titled, Targeting Stat3 in the Myeloid Compartment Drastically Improves the <em>In vivo</em> Antitumor Functions of Adoptively Transferred T Cells

Includes: Supplementary data

Journal Articles

Toll-like Receptor 9 Activation of Signal Transducer and Activator of Transcription 3 Constrains Its Agonist-Based Immunotherapy

Marcin Kortylewski, Maciej Kujawski, Andreas Herrmann, Chunmei Yang, Lin Wang, Yong Liu, Rosalba Salcedo, Hua Yu

Cancer Res (2009) 69 (6): 2497–2505.

https://doi.org/10.1158/0008-5472.CAN-08-3031

Published: 17 March 2009

View article titled, Toll-like Receptor 9 Activation of Signal Transducer and Activator of Transcription 3 Constrains Its Agonist-Based Immunotherapy

Includes: Supplementary data

Journal Articles

Stat3 underlies IL-23-mediated suppression of anti-tumor immunity

Marcin Kortylewski, Hong Xin, Maciej Kujawski, Drew Pardoll, Hua Yu

Cancer Res (2008) 68 (9_Supplement): 4199.

Published: 01 May 2008

View article titled, Stat3 underlies IL-23-mediated suppression of anti-tumor immunity

Journal Articles

Crosstalk between tumor cells and the tumor stroma: a critical role of Stat3 in tumor angiogenesis

Maciej Kujawski, Marcin Kortylewski, Heehyoung Lee, Andreas Herrmann, Hua Yu

Cancer Res (2008) 68 (9_Supplement): 436.

Published: 01 May 2008

View article titled, Crosstalk between tumor cells and the tumor stroma: a critical role of Stat3 in tumor angiogenesis

Journal Articles

Stat3 signaling suppresses toll-like receptor 9-mediated antitumor immune responses

Marcin Kortylewski, Maciej Kujawski, Heehyoung Lee, Hong Xin, Hua Yu

Cancer Res (2007) 67 (9_Supplement): 1591.

Published: 01 May 2007

View article titled, Stat3 signaling suppresses toll-like receptor 9-mediated antitumor immune responses

NARROW

Abstract LB081: Novel targeted oligonucleotide-based telomere disruptor for immunotherapy of diffuse large B-cell lymphoma

Abstract 2364: ABI1 regulates transcriptional activity of STAT3

Abstract 2097: Characterization of mouse and cellular phenotype of ABI1 KO T-cells

Abstract 1570: STAT3 inhibition allows for TLR9-induced reprogramming of acute myeloid leukemia into antigen-presenting cells to generate T-cell mediated immune responses

Abstract 677: Immune biomarkers of response to Ra223 dichloride and stereotactic body radiation therapy in patients with oligometastatic prostate cancers

Abstract 1761: Defining ABI1 role in T-Cell signaling

Abstract 5356: Targeted in vivo delivery of NF-κB decoy oligodeoxynucleotide augments efficacy of radiation therapy against B-cell lymphomas

Abstract LB-058: ABIraterone (ABI) and ENZalutamide (ENZ) induce changes in immunologic profile of patients with metastatic castration-resistant prostate cancer (mCRPC)

Abstract 375: Phenotypic and molecular characterization of circulating tumor cells (CTCs) in patients with castration resistant prostate cancer (CRPC) undergoing treatment with abiraterone acetate or enzalutamide

Abstract CT334: Pazopanib as third-line therapy for metastatic renal cell carcinoma: Clinical efficacy and temporal analysis of cytokine profile

Abstract 2569: Systemic delivery of STAT3 blocking/TLR9 activating oligodeoxynucleotides induces regression of mouse and human acute myeloid leukemia

TLR9 Is Critical for Glioma Stem Cell Maintenance and Targeting

TLR9 Signaling in the Tumor Microenvironment Initiates Cancer Recurrence after Radiotherapy

Abstract LB-334: CpG-STAT3 siRNA for two-pronged immunotherapy of acute myeloid leukemia .

Targeting Stat3 in the Myeloid Compartment Drastically Improves the In vivo Antitumor Functions of Adoptively Transferred T Cells

Toll-like Receptor 9 Activation of Signal Transducer and Activator of Transcription 3 Constrains Its Agonist-Based Immunotherapy

Stat3 underlies IL-23-mediated suppression of anti-tumor immunity

Crosstalk between tumor cells and the tumor stroma: a critical role of Stat3 in tumor angiogenesis

Stat3 signaling suppresses toll-like receptor 9-mediated antitumor immune responses

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only